Net Cash Provided by (Used in) Operating Activities |
-6.79K |
USD |
-24.6% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-3K |
USD |
-105% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
45M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
4.45M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-9.79K |
USD |
-120% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
19.2K |
USD |
-62.3% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
33.5K |
USD |
+10.6% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
33.5K |
USD |
+10.6% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
29.7K |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
-3.2K |
USD |
-10.3% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |